# Evaluation of High Dose Prednisolone Pharmacokinetics in the Acute and Chronic Setting

> **NCT05012033** · — · RECRUITING · sponsor: **Imperial College London** · enrollment: 120 (estimated)

## Conditions studied

- Thyroid Eye Disease
- Vasculitis
- COPD Exacerbation Acute
- Asthma
- Inflammatory Disease

## Interventions

- **OTHER:** No intervention - prednisolone is taken as part if routine clinical care.

## Key facts

- **NCT ID:** NCT05012033
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-04-12
- **Primary completion:** 2030-12
- **Final completion:** 2030-12-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-03-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05012033

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05012033, "Evaluation of High Dose Prednisolone Pharmacokinetics in the Acute and Chronic Setting". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05012033. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*